w1850lumitil12p70humanimmunoassay3 w1851lumitil12p70humanimmunoassay3 w1852lumitil12p70humanimmunoassay3 w185a-c-lumit-human-il-12-standard-3

No-Wash Immunoassay for IL-12

  • ​Cell-based assay with fast add-and-read protocol
  • Luminescent detection with any plate-reading luminometer
  • Scalable to 96- or 384- well plates, protocols included
  • Pack sizes show assay number for 96-well plates

Catalog Number:

Choose a product

Size

Catalog Number: W1850

Please Enquire

Catalog Number: W1851

Please Enquire

Catalog Number: W1852

Please Enquire

Catalog Number: W185A-C

Please Enquire


Request a Sample
Not available in all countries

Overview
Protocols
Specifications
Resources
Related Products

リン酸化または総タンパク質の高速定量

Lumit™ Immunoassay Cellular System は、細胞溶解液に含まれる標的分子を直接測定可能な洗浄のいらない生物発光イムノアッセイです。このアッセイは、適切な一次抗体(お客様提供)が利用可能であれば、あらゆるリン酸化タンパク質、総タンパク質あるいは低分子を検出できるように適合させることができます。

ご参考いただくために、注目度の高いターゲットについて市販の一次抗体を用いて Lumit™ イムノアッセイの評価を行いました。以下のアプリケーションノートには、試用した各一次抗体用のプロトコル、サンプルデータ、最適化条件、および注文情報が記載されされています。

How the Lumit® IL-12 Immunoassay Works

Primary antibodies to IL-12 were selected for their specific and sensitive detection and labeled with the LgBiT and SmBiT subunits of NanoBiT® Luciferase. In the presence of IL-12, the subunits are brought together to form an active luciferase enzyme. Addition of optimized substrate generates a bright luminescent signal proportional to IL-12 levels. The assay is specific for the IL-12p70 (A/B heterodimer); it is effective for detection of IL-12p70 in presence of 100-fold excess of either IL-12B subunit, IL-12p80 or IL-23.

Schematic of Lumit® IL-12 Immunoassay concept showing LgBiT and SmBiT binding protein binding to IL-12 and forming NanoBiT® Luciferase.

Simple One-Plate Protocol Requires No Wash Steps

Lumit® IL-12 p70 (Human) Immunoassay workflow.

Lumit™ イムノアッセイ vs. ウェスタンブロッティング

Lumit™ イムノアッセイ はウェスタンブロッティングと較べてより簡単で迅速に同等のデータを得ることができます。

 

Graph showing standard curve for Lumit® IL-12 p70 (Human) Immunoassay.

Specification

Lumit® IL-12 (Human) Immunoassay

Dynamic Range

18.2–25,000pg/ml

Limit of Detection (LOD)

10.4pg/ml (3 SD above background)

Minimal Detectable Dose (MDD)

7.1pg/ml (2 SD above background)

Assay Time

70 minutes

Sample Type

Cell culture supernatants

SD=Standard Deviation

High-Throughput Screening Applications

Optimizing the Lumit® IL-6 Immunoassay for High-Throughput Drug Screening

In this webinar, we share key considerations for scaling Lumit® Immunoassays from a single 96-well plate to many 364-well plates and offer tips for optimizing Lumit® Immunoassays for HTS applications. You will also hear Galapagos scientist Dr. Nick Verstraeten share how his team used the Lumit® IL-6 Immunoassay in a screening campaign for antiviral drugs.

View On-Demand Webinar

Lumit® Cytokine Assay Automation for High-Throughput Screening

In this poster, see miniaturization and automation data for Lumit® cytokine assays.

View Poster

Sensitive Detection of IL-12 p70 Released from Human PBMCs

 

Line graph showing a dose-dependent increase in IL-12 p70 secretion from PBMC cells treated with IFN-γ, further enhanced by LPS.

Human PBMCs (100,000 cells/well) were pretreated with IFN-ɣ and then stimulated with increasing concentrations of LPS. After treatment, Lumit® IL-12 Immunoassay was used to quantify IL-12 release.

 

Need to measure a different target?

View our growing portfolio of
Lumit® Immunoassays.

For a biotech that understands time is of significant value, the Lumit® Immunoassays are an essential way for us to gather reliable data fast so that we can reach conclusions and make decisions sooner.

Jonathan Chow, Principal Scientist, Corner Therapeutics

Specifications

Catalog Number:

選択製品の構成品内容

Item Part # Size

Lumit® Detection Substrate B

VB405A 1 × 160μl

Lumit® Detection Buffer B

VB406A 1 × 3.2ml

Anti-hIL-12 mAb-LgBiT, 500X

W157A 1 × 30μl

Anti-hIL-12 mAb-SmBiT, 500X

W186A 1 × 30μl

Human IL-12 Standard

W185A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

Lumit® Detection Substrate B

VB405B 1 × 1.25ml

Lumit® Detection Buffer B

VB406B 1 × 25ml

Anti-hIL-12 mAb-LgBiT, 500X

W157B 1 × 300μl

Anti-hIL-12 mAb-SmBiT, 500X

W186B 1 × 300μl

Human IL-12 Standard

W185A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

Lumit® Detection Substrate B

VB405A 5 × 160μl

Lumit® Detection Buffer B

VB406A 5 × 3.2ml

Anti-hIL-12 mAb-LgBiT, 500X

W157A 5 × 30μl

Anti-hIL-12 mAb-SmBiT, 500X

W186A 5 × 30μl

Human IL-12 Standard

W185A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA

パテントおよび免責条項

U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.

U.S. Pat. Nos. 9,797,889, 9,797,890, 10,107,800 and 11,493,504; European Pat. No. 2970412; Japanese Pat. Nos. 7280842 and 7532562; and other patents and patents pending.

選択製品の構成品内容

Item Part # Size

Human IL-12 Standard

W185A 1 × 25μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

AA